Brian Daley is a partner at Norton Rose Fulbright in Canada for which he is the Pharmaceutical and Life Sciences International Business Group leader. He practises in all areas of intellectual property law, with a focus on patents, trademarks and litigation at the trial, appellate and Supreme Court level. He has particular expertise in regulatory matters and litigation involving pharmaceutical and mechanical patents. Mr. Daley is often retained to act as lead counsel on complex patent litigation. This includes patent infringement actions, as well as summary proceedings under Canada's Patented Medicines (Notice of Compliance) Regulations. He has also successfully defended damages claims brought by generic pharmaceutical companies who claim to have been kept off the market because of proceedings brought by patentees. He recently successfully fought motions for interim and interlocutory injunctions. Mr. Daley is a frequent presenter to professional organizations and companies, as well as a contributor to publications in the intellectual property and regulatory fields in North America and Europe. Called to the Québec Bar in 1994. He is a member of the Intellectual Property Institute of Canada (IPIC) and the American Intellectual Property Law Association (AIPLA).